Folks

I went for a walk and conclude the following.

- from a data perspective, nothing in the presentation would reverse the sharp decline from 4.95-1.80...

...good news is that there is no stoppage of the trial from a scientific perspective. 

- better  news I assume all the executives would have know this data at the time Don said hang in but based on volume there was no mass selling. (why) - which leaves 2 possibilities

-a)-RVX is confident of some positive from the FDA -of which the discussion aleady happened but feedback not disclosed.

-b)- this data was shared with potental partner and there was a positive expectation only, hence the need for " hold on" by the CEO

so where does that leave us.

...  unless there is a firm disclosure on one of the above 2 topics-we will be looking south badly.. however, if there is only an expression of confidence for a positive expectation  of one of those scenarios we are looking at $1. If a takeover happens- will be about 4-5/share...just a "man in the street thoughts."

d

thanks